Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Assets Average (2016 - 2026)

Tandem Diabetes Care filings provide 12 years of Assets Average readings, the most recent being $877.9 million for Q4 2025.

  • On a quarterly basis, Assets Average fell 8.81% to $877.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $877.9 million, a 8.81% decrease, with the full-year FY2025 number at $924.4 million, down 3.73% from a year prior.
  • Assets Average hit $877.9 million in Q4 2025 for Tandem Diabetes Care, roughly flat from $875.2 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $1.1 billion in Q4 2022 to a low of $735.3 million in Q1 2021.
  • Median Assets Average over the past 5 years was $945.6 million (2023), compared with a mean of $926.3 million.
  • Biggest five-year swings in Assets Average: soared 119.69% in 2021 and later dropped 9.89% in 2023.
  • Tandem Diabetes Care's Assets Average stood at $877.7 million in 2021, then grew by 19.65% to $1.1 billion in 2022, then fell by 9.89% to $946.3 million in 2023, then increased by 1.73% to $962.7 million in 2024, then decreased by 8.81% to $877.9 million in 2025.
  • The last three reported values for Assets Average were $877.9 million (Q4 2025), $875.2 million (Q3 2025), and $898.9 million (Q2 2025) per Business Quant data.